| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 0 | 60.463 | 42.576 |
| Total Income - EUR | - | - | - | - | - | - | - | 0 | 60.463 | 42.576 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 62 | 27.660 | 39.259 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | -62 | 32.803 | 3.317 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | -62 | 32.210 | 2.190 |
| Employees | - | - | - | - | - | - | - | 0 | 1 | 1 |
Check the financial reports for the company - Balaban Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 62 | 21.873 | 21.751 |
| Current Assets | - | - | - | - | - | - | - | 20 | 49.479 | 35.411 |
| Inventories | - | - | - | - | - | - | - | 0 | 5.162 | 15.289 |
| Receivables | - | - | - | - | - | - | - | 0 | 34.428 | 3.000 |
| Cash | - | - | - | - | - | - | - | 20 | 9.889 | 17.122 |
| Shareholders Funds | - | - | - | - | - | - | - | -42 | 32.168 | 2.388 |
| Social Capital | - | - | - | - | - | - | - | 20 | 20 | 20 |
| Debts | - | - | - | - | - | - | - | 125 | 39.184 | 54.774 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Balaban Medical S.r.l.